Cargando…

Association of tumor mutation burden and epidermal growth factor receptor inhibitor history with survival in patients with metastatic stage III/IV non-small-cell lung cancer: A retrospective study

OBJECTIVES: Lung cancer is the leading cause of cancer-related deaths worldwide. However, factors associated with the survival of patients with advanced non-small-cell lung cancer (NSCLC) who received only hospice care are largely unclear. In this study, we aimed to determine the prognostic factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Yan, Zhou, Shuo, Feng, Weihong, Qiao, Ying, Du, Xueming, Li, Fenge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculdade de Medicina / USP 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955145/ https://www.ncbi.nlm.nih.gov/pubmed/33787673 http://dx.doi.org/10.6061/clinics/2021/e2251

Ejemplares similares

Metastatic lymph node burden impacts overall survival in submandibular gland cancer
por: Wang, Lei, et al.
Publicado: (2023)

Radical surgery for stage IV gallbladder cancers: Treatment strategies in patients with limited metastatic burden
por: Patkar, Shraddha, et al.
Publicado: (2023)

Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients
por: Aoude, Lauren G., et al.
Publicado: (2020)

Impact of Cytological Sampling on EGFR Mutation Testing in Stage III-IV Lung Adenocarcinoma
por: Davies, Rhian Siân, et al.
Publicado: (2017)

The cost of unresectable stage III or stage IV melanoma in Italy
por: Maio, Michele, et al.
Publicado: (2012)

Survival benefit of adjuvant radiotherapy in stage III and IV bladder cancer: results of 170 patients
por: Bayoumi, Yasser, et al.
Publicado: (2014)

A History of Magic and Experimental Science. Vols. III and IV
Publicado: (1935)

Epidermal Growth Factor Receptor-Targeted Neoantigen Peptide Vaccination for the Treatment of Non-Small Cell Lung Cancer and Glioblastoma
por: Li, Fenge, et al.
Publicado: (2023)

The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer
por: Wang, Ru, et al.
Publicado: (2019)

A Retrospective Study on Using a Novel Single Needle Cone Puncture Approach for the Iodine-125 Seed Brachytherapy in Treating Patients With Thoracic Malignancy
por: Li, Fenge, et al.
Publicado: (2021)

A Robust Seven-Gene Signature Associated With Tumor Microenvironment to Predict Survival Outcomes of Patients With Stage III–IV Lung Adenocarcinoma
por: Zhao, Hao, et al.
Publicado: (2021)

Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
por: Mandalá, Mario, et al.
Publicado: (2021)

A methylomics-associated nomogram predicts the overall survival risk of stage III to IV ovarian cancer
por: Wei, Xuan, et al.
Publicado: (2023)

Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer
por: Cho, Jang Ho, et al.
Publicado: (2017)

Analysis of Beta-Tubulin Gene Exon 4 Mutations in Advanced Stage III or IV Gastric Cancer
por: Tahara, Tomomitsu, et al.
Publicado: (2007)

Survival Outcomes with Photodynamic Therapy, Chemotherapy and Radiation in Patients with Stage III or Stage IV Non-Small Cell Lung Cancer
por: Chhatre, Sumedha, et al.
Publicado: (2021)

The prediction model of operative link on gastric intestinal metaplasia stage III-IV: A multicenter study
por: Wang, Song, et al.
Publicado: (2023)

Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer
por: van Uden, D. J. P., et al.
Publicado: (2019)

Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population‐based analysis
por: Wang, Jiwei, et al.
Publicado: (2019)

Survival Impact of Nephroureterectomy for De Novo Stage IV Nonmetastatic and Metastatic Upper Tract Urothelial Carcinoma
por: Lin, Wei-Yu, et al.
Publicado: (2022)

A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study
por: Shi, Huaqing, et al.
Publicado: (2022)

Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer?
por: Braun, Donald P, et al.
Publicado: (2011)

Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy
por: Jin, Hailong, et al.
Publicado: (2013)

Survival Outcomes and Patterns of Recurrence in Patients with Stage III or IV Oropharyngeal Cancer Treated with Primary Surgery or Radiotherapy
por: Debenham, Brock J, et al.
Publicado: (2016)

30 Years of Experience in the Management of Stage III and IV Epithelial Ovarian Cancer: Impact of Surgical Strategies on Survival
por: Delga, Berenice, et al.
Publicado: (2020)

Stage IV EGFR Mutation-Negative and ALK Mutation-Negative Lung Adenocarcinoma: Long-Term Survival is Possible
por: Kedia, Shiksha, et al.
Publicado: (2015)

Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non–Small Cell Lung Cancer
por: Su, Chloe C., et al.
Publicado: (2023)

Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors
por: Tsai, Ming-Ju, et al.
Publicado: (2018)

The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis
por: Chang, Wei-Yuan, et al.
Publicado: (2018)

Adjuvant therapies in stages I–III epidermal growth factor receptor-mutated lung cancer: current and future perspectives
por: Kris, Mark G., et al.
Publicado: (2023)

A Short History of Nautical Medicine (Parts I, II, III, IV)
por: Roddis, Louis H.
Publicado: (1941)

Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
por: Los-de Vries, G. Tjitske, et al.
Publicado: (2022)

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
por: van den Broek, Evert, et al.
Publicado: (2016)

Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2013)

The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients
por: Uprety, Dipesh, et al.
Publicado: (2018)

c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients
por: Lin, Shu-Hui, et al.
Publicado: (2019)

Developing Preoperative Nomograms to Predict Any-Stage and Stage III-IV Endometriosis in Infertile Women
por: Guo, Zaixin, et al.
Publicado: (2020)

Surgical Survival Benefits With Different Metastatic Patterns for Stage IV Extrathoracic Metastatic Non-Small Cell Lung Cancer: A SEER-Based Study
por: Chao, Ce, et al.
Publicado: (2021)

Immune phenotype of patients with stage IV metastatic inflammatory breast cancer
por: Fernandez, Sandra V., et al.
Publicado: (2020)

Biomarker analysis in stage III–IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival
por: Kim, J-S, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_23lp8h3an0ococ02qn2lhpguvt